Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Vey

Showing results (91-100 of 251) with videos related to

Pageof 26
Sort By:
Intensive Care Medicine|November 16, 2013
De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational studyDjamel Mokart, Géraldine Slehofer, Jérôme Lambert, et al.
Haematologica|October 16, 2012
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblastsVéronique Gelsi-Boyer, Nathalie Cervera, François Bertucci, et al.
Cancer|May 25, 2005
Acute leukemia during pregnancy: a report on 37 patients and a review of the literatureYoucef Chelghoum, Norbert Vey, Emmanuel Raffoux, et al.
Haematologica|March 24, 2018
Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytesStéphanie Gon, Marie Loosveld, Thomas Crouzet, et al.
Experimental Hematology|November 13, 2004
CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantationMohamad Mohty, Sophie Bagattini, Christian Chabannon, et al.
Oncotarget|May 1, 2018
A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignanciesNorbert Vey, Lionel Karlin, Sophie Sadot-Lebouvier, et al.
Cancer|July 9, 2004
The benefit of induction chemotherapy in patients age > or = 75 yearsNorbert Vey, Diane Coso, Valerie-Jeanne Bardou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failureThomas Prébet, Steven D Gore, Benjamin Esterni, et al.
Haematologica|August 3, 2014
Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignanciesClaire Oudin, Patrice Chevallier, Sabine Furst, et al.
Genes, Chromosomes & Cancer|July 25, 2019
Targeted molecular characterization shows differences between primary and secondary myelofibrosisFrédéric Courtier, Séverine Garnier, Nadine Carbuccia, et al.
Pageof 26

Showing results (91-100 of 251) with videos related to

Sort By:
Pageof 26
Intensive Care Medicine|November 16, 2013
De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational studyDjamel Mokart, Géraldine Slehofer, Jérôme Lambert, et al.
Haematologica|October 16, 2012
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblastsVéronique Gelsi-Boyer, Nathalie Cervera, François Bertucci, et al.
Cancer|May 25, 2005
Acute leukemia during pregnancy: a report on 37 patients and a review of the literatureYoucef Chelghoum, Norbert Vey, Emmanuel Raffoux, et al.
Haematologica|March 24, 2018
Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytesStéphanie Gon, Marie Loosveld, Thomas Crouzet, et al.
Experimental Hematology|November 13, 2004
CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantationMohamad Mohty, Sophie Bagattini, Christian Chabannon, et al.
Oncotarget|May 1, 2018
A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignanciesNorbert Vey, Lionel Karlin, Sophie Sadot-Lebouvier, et al.
Cancer|July 9, 2004
The benefit of induction chemotherapy in patients age > or = 75 yearsNorbert Vey, Diane Coso, Valerie-Jeanne Bardou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failureThomas Prébet, Steven D Gore, Benjamin Esterni, et al.
Haematologica|August 3, 2014
Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignanciesClaire Oudin, Patrice Chevallier, Sabine Furst, et al.
Genes, Chromosomes & Cancer|July 25, 2019
Targeted molecular characterization shows differences between primary and secondary myelofibrosisFrédéric Courtier, Séverine Garnier, Nadine Carbuccia, et al.
Pageof 26